S&P 500: 1,317.11 Change: -0.21%

PaulShark

P&P Score: 2.00 Points: -68.56 Accuracy: 0.00% Average Pick Score: -34.28 Annual Return: 1.23% (1.75% since 12/23/10)

PaulShark's Blog : Hypertension Diagnostics Inc.

December 28, 2010

Comments (0) Rate this post

Recommend This Post (77) Abuse this post

Report Abuse

Share This

Hypertension Diagnostics, Inc. engaged in design, development, manufacture and marketing of devices that non-invasively measure both large and small artery elasticity. The Company’s product provides cardiovascular parameters. The Company markets three products: CVProfilor DO-2020 CardioVascular Profiling System, HDI/PulseWaveCR-2000 Research CardioVascular Profiling System and CVProfilor MD-3000 CardioVascular Profiling System. The CVProfilor DO-2020 System is being marketed to care physicians and other health care professionals within the United States. These physicians and other health care professionals can purchase the CVProfilor DO-2020 directly from it, lease it through a third-party capital lease, or rent it from the Company on a per-patient-tested rental basis. Utilizing its Central Data Management Facility (CDMF), it tracks utilization of the CVProfilor DO-2020 System in each physician’s office and medical clinic.

RESEARCH: http://www.goo.gl/0lphB

Tags : HDII ACL HTWR BAX COV BDX CASM CSCX CRDC DXR DSCI.OB ECI IMUC.OB INHI.OB IVD ISR MELA MLSS.OB MLAB NEPH.OB NMTI NURO OISI.OB OCLS PDEX RPC RVP SDIX TSON UNIS UPI ATEC ATRC BEAT CDIC CSII CTE CVBT.OB HBIO KNSY LMAT NSPH OSUR VITA ROCM TOMO UTMD VASC MEND

Want to comment on this post? Sign up now. It's FREE!
Already registered? Log In.

Sponsored Links

Zacks Top Ten Stocks for 2011 are now available! This 10-stock portfolio is a well-balanced mix of aggressive and conservative, large and small cap, growth and value. Buy them. Hold them. Watch your gains add up

Make Big Bucks promoting Zacks products on your website! Click here to Learn about Zacks' Affiliate program.

With Zacks Method for Trading you'll transform yourself into a Master Stock Trader, one simple step at a time. Get step-by-step instructions and learn how to use the 28% per year Zacks Rank system to find market-beating stocks on your own, fully exploiting the system that beat the market 18 of the last 20 years. Find out how >>

Stock screening and chart patterns expert, Kevin Matras, combs through the best Zacks stock-picking strategies averaging +60% yearly gains to find stocks with charts showing they are ready to skyrocket. Chart Patterns Trader >>